← back to search

Sabine Huenecke

Goethe University Frankfurt · DE
Area of research
Immunology · Hematology
Research interest
Research interests include Immune Cell Function and Interaction, Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, and T-cell and B-cell Immunology.
h-index
25
citations
1,971
works
87
NIH funding
primary concept
email

Recent publications

Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Journal of Translational Medicine 2023cited by 18position: middledoi
Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel
Frontiers in Immunology 2022cited by 49position: middledoi
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
Cancer Cell 2022cited by 43position: middledoi
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
Frontiers in Immunology 2017cited by 109position: middledoi
Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections
Frontiers in Immunology 2017cited by 38position: firstdoi
T‐lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: A randomized controlled trial with sequential crossover
Diabetes/Metabolism Research and Reviews 2016cited by 45position: middledoi
Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation
Biology of Blood and Marrow Transplantation 2016cited by 40position: middledoi
Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience
Bone Marrow Transplantation 2016cited by 30position: middledoi
5-Lipoxygenase Is a Direct Target of miR-19a-3p and miR-125b-5p
The Journal of Immunology 2015cited by 59position: middledoi
Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial
Blood 2015cited by 20position: middledoi
Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
Frontiers in Oncology 2013cited by 139position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Bader · Children's Clinical University Hospital6 papers (2015–2023)Thomas Klingebiel · Goethe University Frankfurt6 papers (2013–2022)Melanie Bremm · Goethe University Frankfurt6 papers (2013–2022)Evelyn Ullrich · Goethe University Frankfurt5 papers (2013–2022)Claudia Cappel · University Hospital Frankfurt5 papers (2016–2022)Andrea Jarisch · Goethe University Frankfurt4 papers (2016–2022)Jan Soerensen · University of Tübingen4 papers (2013–2017)Shahrzad Bakhtiar · Goethe University Frankfurt3 papers (2016–2017)Ulrike Koehl · Innovation Cluster (Canada)3 papers (2013–2016)Eva Rettinger · University Hospital Frankfurt3 papers (2016–2022)Gesine Bug · German Cancer Research Center3 papers (2015–2023)Emilia Salzmann‐Manrique · Goethe University Frankfurt3 papers (2016–2017)Hermann Kreyenberg · Goethe University Frankfurt3 papers (2016–2022)Verena Pfirrmann · University Hospital Frankfurt2 papers (2016–2017)Stephanie Erben · Goethe University Frankfurt2 papers (2013–2022)André Willasch · Goethe University Frankfurt2 papers (2016–2016)Eileen Auth · Goethe University Frankfurt2 papers (2013–2015)Hubert Serve · Goethe University Frankfurt2 papers (2015–2022)Julia Banisharif-Dehkordi · University Hospital Frankfurt2 papers (2017–2022)Peter Bader · Goethe University Frankfurt2 papers (2013–2017)